Literature DB >> 3361448

Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells.

K Ohno1, T Sakai, M Fukushima, S Narumiya, M Fujiwara.   

Abstract

HeLa S3 cells were enriched in the G1 phase of cell cycle by serum starvation and used for analysis of prostaglandin (PG) effect on cell cycle progression. Cell cycle progression was initiated by incubating the G1-enriched cells with fresh medium containing 10% fetal calf serum and analyzed in the presence of 40 nM colcemid to block renewal of the cycle. When progression of control cells was analyzed under these conditions, time-dependent decrease in the number of G1 phase cells and increase in that of G2/M phase cells were observed during the 24-hr incubation. Cells in S phase increased transiently during this period. Proportions of cells in G1 and G2/M phases were 65 and 15% of the total cells at 0 hr and 10 and 80% at 24 hr, respectively. When the cells were treated with either PGA2 or 9-deoxy-delta 9,12-13,14-dihydroprostaglandin D2 (delta 12-PGJ2) for more than 3 hr, inhibition of G1 phase progression became evident 3 to 6 hr after the PG addition. Progression through S phase was slowed but not arrested with the PG treatment. When cells treated with PGA2 were washed and transferred to fresh medium, G1 phase progression was resumed and transition to S phase was observed about 6 hr after the wash. However, the arrest by delta 12-PGJ2 was irreversible and no recovery was observed with washing of the cells treated with this PG. The sensitivities of cells to PG in different phases of cell cycle were compared by treating G2/M phase cells with delta 12-PGJ2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3361448

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen.

Authors:  S H Khan; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Effects of cytotoxic prostaglandin, delta 12-PGJ2 on protein synthesis and cytoskeleton in transformed epidermal cells in culture.

Authors:  K Ikai; M Fukushima
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Induction of HSP70 gene expression by the antiproliferative prostaglandin PGA2: a growth-dependent response mediated by activation of heat shock transcription factor.

Authors:  N J Holbrook; S G Carlson; A M Choi; J Fargnoli
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

4.  Anti-cancer-prostaglandin-induced cell-cycle arrest and its modulation by an inhibitor of the ATP-dependent glutathione S-conjugate export pump (GS-X pump).

Authors:  T Ishikawa; K Akimaru; M Nakanishi; K Tomokiyo; K Furuta; M Suzuki; R Noyori
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

Review 5.  Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells.

Authors:  Y Kikuchi; T Kita; J Hirata; M Fukushima
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

6.  Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia.

Authors:  Tatsurou Yagami
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

7.  N-Polybenzylated alicyclic 1,2-diamines: cytotoxicity and G1 phase arrest in cancer cell line.

Authors:  Antonio Caldarelli; Valeria De Biasio; Giovanni B Giovenzana; Gianpiero Mastronardo; Roberto Negri
Journal:  Mol Divers       Date:  2014-06-28       Impact factor: 2.943

8.  A new aspect on glutathione-associated biological function of MRP/GS-X pump and its gene expression.

Authors:  T Ishikawa; M T Kuo; K Furuta; M Suzuki
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.